title: Defining tumor antigens: mRNA, protein or cytotoxicity?
authors.forename: Seah H
authors.initials: SH
authors.lastname: Lim
authors.forename: Phillip
authors.initials: P
authors.lastname: Periman
authors.forename: Panpit
authors.initials: P
authors.lastname: Klug
authors.forename: Jon
authors.initials: J
authors.lastname: Weidanz
authors.forename: Vaughan
authors.initials: V
authors.lastname: Whitton
authors.forename: Maurizio
authors.initials: M
authors.lastname: Chiriva-Internati
authors.forename: Zhiqing
authors.initials: Z
authors.lastname: Wang
authors.forename: Stephen
authors.initials: S
authors.lastname: Wright
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009363:Neoplasm Proteins / Q000235:genetics* / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D012333:RNA, Messenger; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53